Solara Active Pharma Income Statement

Quarterly

Yearly

home icon
The current prices are delayed, login to your account to see live prices.
LOGIN
202120222023
EBITDA414990
EBIT305-160
Earning Per Share64-16-6
Expenses1,2311,1881,310
Net Profit221-58-22
Net Profit Margin14-5-2
Operating Profit Margin26811
Profit Before Tax222-91-45
Dividends Per Share700
Operation Revenue1,6461,2881,466

Peer Comparison (in ₹.Cr.)

CompanyYearEBITEBITDANet ProfitNet WorthProfit Before Tax
20230080.62NA86.80
20221,739.202,486.90993.609,042.131,441.20
202300447.69NA716.49
2023004,470.30NA6,011.50
2023008,560.84NA9,408.43
The EBITDA of Solara Active Pharma is 0 as of 2/24/2024
home icon
The current prices are delayed, login to your account to see live prices.
LOGIN
20182019202020212023
Operating Activities49166242155156
Investing Activities-85-116-359-106-81
Financing Activities68-239792-113
Others00000
Net Cash Flow3127-20142-38

Peer Comparison (in ₹.Cr.)

CompanyYearOperating ActivitiesInvesting ActivitiesFinancing ActivitiesNet Cash Flow
2021-2.18-34.87-15.36-52.41
2023625.39-528.49-77.4619.45
20201,468.841,106.99-890.581,685.25
20235,887.50-4,137.30-2,686.10-935.90
20234,959.33-7,943.682,376.07-608.28
The cash flow from Operating Activities of Solara Active Pharma is 156 as of 2/24/2024